Thought Leadership

John Squires Faces the Senate Judiciary Committee  

HHS Sets Most-Favored-Nation Price Targets for Pharmaceuticals 

Acting USPTO Director Stewart Issues First Decisions Under Interim Discretionary Denial Process

No Space at the Trademark Office for US SPACE FORCE

How Trump’s Latest Drug Price EO Could Impact Pharma

Taking a Good Deposition, Part III: Conversations, Exhibits, Whether to Hold Your Fire at Deposition, and Dealing with Obstreperous Counsel

Patent Diligence for VCs and PEs

ITC Round-Up: Q1 2025

Federal Circuit Clarifies Limits of Patent Eligibility for Machine Learning Claims

More Is More: Ensure Your Mark Is Protectable Before You Enforce

Can Clinical Trials Negate Patentability for Pharma Inventions?

PTAB Issues FAQs on Interim Process for Workload Management